Delivery Order SPE2DB24D2100-SPE2DB25FBFRG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,061.12 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price contract, which is not set-aside, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a contract value of $1,849.44 and a completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,908.70 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $19,159.17 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract, awarded on September 25, 2025, is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $5,149.00 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This firm fixed-price delivery order, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a competitively awarded, non-set-aside contract. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.68 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,837.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL vaccine syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract was performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFRGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $1,147.92 on August 5, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 6, 2025, and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant $999.99 billion prime indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX) through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. This underlying contract enables the company to supply a broad range of pharmaceutical products, vaccines, medical devices, and healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The current delivery order for the hepatitis B vaccine reflects the company's role as a critical vendor within DLA's medical supply chain and demonstrates the ongoing execution of pharmaceutical procurement needs within the federal military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/5/25 |